|
 |
 |
| Among the applications of PSYCHOLOGIX® technology is precise assessment of drug effects on cognition, behavior, and mood. To learn more select one of the topics: |
| |
|
|
| |
Applications of Tests
- Measures of Efficacy in Clinical Drug Trials in Age-Associated Memory Impairment (AAMI), Age-Related Coginitive Decline (ARCD), Mild Cognitive Impairment (MCI), and Other Conditions Marked By Cognitive Loss
- Measures of Cognitive Effects of Drugs Developed for the Full Range of Medical and Psychiatric Disorders
- Screening Potential Study Subjects for Cognitive Disorders
- Measuring Cognitive Drug Effects Among Large Numbers of Community-Dwelling Subjects in Phase IV Studies
- Following Large Numbers of Commmunity-Dwelling Subjects to Detect Onset of Alzheimer's Disease and Other Neurologic Disorders
- Allowing Persons in the Community to Compare Their Scores on Cognitive Tests With Those of Comparable Persons
- Allowing Persons in the Community to Assess Changes in Their Cognitive Performance Over the Course of Months or Years
- Allowing Persons in the Community, Their Family Members, or Physicians to Assess the Effects of Treatments on Cognition
|
|
